Orient Biotech
68829818.892.44% ( +0.45 )
Orient Biotech (688298)
Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant dia...
- Open
- 18.41
- High
- 18.95
- Low
- 18.41
- Prev. Close
- 18.44
- Volume
- 12.69K
- Turnover
- 23.84M
- Avg Price
- 18.79
- Bid/Ask Ratio
- --
- Amplitude
- 2.93%
- 52wk High
- 30.60
- Volume Ratio
- 0.59
- Turnover Ratio
- 0.63%
Orient Biotech Analyst Rating
View MoreForecast & Rating
Jul 4, 2022Price forecast
¥174.40823.27%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Wallstreetcn · Jan 25 at 11:15 PM
The A-share biopharmaceutical sector continues to strengthen, with Maccura, Hybribio Biotech, and KHB hitting the daily limit up in the afternoon. LIFERIVER and DAJY had previously reached their limit up, while WONDFO BIOTECH, ACROBIOSYSTEMS, Orient Biotech, and SSSW rose over 10%
- Zhitong · Sep 22, 2025 at 03:13 AM
Orient Biotech's subsidiary has obtained registration certificates for two medical device products
- Zhitong · Sep 11, 2025 at 06:18 AM
Orient Biotech: Completed the repurchase of 1.8013 million shares
- Zhitong · Sep 9, 2025 at 04:17 AM
Orient Biotech's subsidiary obtains medical device registration certificate
- Zhitong · Aug 28, 2025 at 06:49 AM
Orient Biotech: Net loss of 163 million yuan in the first half of 2025
- Zhitong · Jul 16, 2025 at 05:42 PM
Institutional Deployment: Structural Opportunities Become Market Consensus
